There is a paradox at the heart of Microsoft's current stock market run. The company closed out its fiscal year...

The numbers were never really in doubt. When Munich Re confirmed its full second-quarter results on August 7, 2026, the...

The Cologne-based engine maker is navigating one of the most consequential periods in its corporate history, with momentum in its...

The arithmetic of the current memory-chip cycle is brutal: a company can post record numbers, beat every estimate on the...

The arithmetic at Rheinmetall has rarely looked so contradictory. First-half sales jumped 39 percent to €5.2 billion, operating profit surged...

TKMS has been doing the kind of quiet, persistent work that usually gets noticed only after the fact: the stock...

The market has delivered a brutal verdict on Spero Therapeutics' corporate reinvention. Shares in the biotech group have tumbled roughly...

The narrative that has defined Bayer for half a decade is finally shifting. For years, the chemicals-to-pharma group was the...

The arithmetic looks brutal on its face. Navitas Semiconductor lost $228.22 million in the second quarter of 2026, its stock...

The final day of July brought a quiet revolution in German social policy. A sweeping cost-containment law for the statutory...